Authors: JUNG SH LLOYD RV RUSH WR PRZYGODZKI R CAPORASO N FLEMING MV BENNETT W PAIROLERO P TRASTEK V JETT JR LIOTTA LA HARRIS CC TAZELAAR HD TRAVIS WD

Citation: Sh. Jung et al., IN-SITU HYBRIDIZATION (ISH) FOR TRANSFORMING-GROWTH-FACTOR (TGF)-BETA-1, (TGF)-BETA-3, AND TGF-RECEPTOR-II (RII) MESSENGER-RNA IN NONSMALL CELL LUNG-CARCINOMA (NSCLC), Modern pathology, 11(1), 1998, pp. 176-176

Authors: FLIEDER DB FALK R RUSH WR FLEMING MV GAL A KOSS M TRAVIS W

Citation: Db. Flieder et al., PROPOSED MODIFIED HISTOLOGIC CRITERIA FOR DIAGNOSIS OF ATYPICAL CARCINOID-TUMORS, Laboratory investigation, 76(1), 1997, pp. 962-962

Authors: PENMAN AD EADIE J HERRON WJ REILLY MA RUSH WR LIU Y

Citation: Ad. Penman et al., THE CHARACTERIZATION OF THE METABOLITES OF RANOLAZINE IN MAN BY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY (VOL 9, PG 1418, 1995), Rapid communications in mass spectrometry, 10(1), 1996, pp. 150-150

Authors: PENMAN AD EADIE J HERRON WJ REILLY MA RUSH WR LIU Y

Citation: Ad. Penman et al., THE CHARACTERIZATION OF THE METABOLITES OF RANOLAZINE IN MAN BY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY, Rapid communications in mass spectrometry, 9(14), 1995, pp. 1418-1430

Authors: RUSH WR MURRAY GR GRAHAM DJM

Citation: Wr. Rush et al., THE COMPARATIVE STEADY-STATE BIOAVAILABILITY OF THE ACTIVE INGREDIENTS OF MADECASSOL, European journal of drug metabolism and pharmacokinetics, 18(4), 1993, pp. 323-326